Salmonella discovery offers new hope for bowel cancer therapies
A new discovery by Cancer Research UK-funded researchers in Birmingham and Glasgow brings us a step closer to using Salmonella to fight bowel cancer.
- Published: 19 November 2024
Filter
63 results were found based on your search term
A new discovery by Cancer Research UK-funded researchers in Birmingham and Glasgow brings us a step closer to using Salmonella to fight bowel cancer.
A recent Experimental Medicine Award will allow researchers to learn more about the genetic and epigenetic causes of cancer, through an existing trial.
Dr Shivan Sivakumar explains how mRNA vaccines help us treat cancer, as we open Europe’s first site for pancreatic cancer vaccine trial.
University of Birmingham research is leading the way in pancreatic cancer vaccine trials.
Experts in infectious diseases, immune diagnostics and vaccines who have been working in Rwanda for years and will now engage on the needs of disease outbreak.
New funding will allow Birmingham researchers to better predict which genetic alterations increase the risk of vulval cancer.
Newly funded research will help identify new drug targets by improving understanding of how the fungal pathogen Candida albicans subverts immune response.
The study will explore the potential of faecal microbiota transplantation to slow the progression of primary sclerosing cholangitis.